BNP Paribas Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-10,129
| Closed | -$1.17M | – | 874 |
|
2023
Q3 | $1.17M | Sell |
10,129
-799
| -7% | -$92.5K | ﹤0.01% | 717 |
|
2023
Q2 | $1.12M | Buy |
10,928
+717
| +7% | +$73.7K | ﹤0.01% | 717 |
|
2023
Q1 | $1.11M | Sell |
10,211
-673,689
| -99% | -$73.5M | ﹤0.01% | 743 |
|
2022
Q4 | $77.8M | Sell |
683,900
-384,413
| -36% | -$43.7M | 0.28% | 90 |
|
2022
Q3 | $66.1M | Buy |
1,068,313
+358,243
| +50% | +$22.2M | 0.26% | 87 |
|
2022
Q2 | $56.6M | Buy |
710,070
+116,024
| +20% | +$9.25M | 0.22% | 117 |
|
2022
Q1 | $62.5M | Buy |
594,046
+36,155
| +6% | +$3.8M | 0.22% | 106 |
|
2021
Q4 | $60.1M | Buy |
557,891
+212,466
| +62% | +$22.9M | 0.2% | 118 |
|
2021
Q3 | $37.8M | Buy |
345,425
+20,452
| +6% | +$2.24M | 0.14% | 183 |
|
2021
Q2 | $30.4M | Buy |
324,973
+194,646
| +149% | +$18.2M | 0.11% | 234 |
|
2021
Q1 | $12M | Buy |
130,327
+126,530
| +3,332% | +$11.6M | 0.05% | 377 |
|
2020
Q4 | $278K | Buy |
+3,797
| New | +$278K | ﹤0.01% | 811 |
|